glutathione production in cancer cells Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of lung by reprograming the tumor microenvironment Glutathione production by cancer cells

All peptide GLP-1 agonists were developed as subcutaneous injections because peptides face three fundamental barriers to oral bioavailability

Some inflammatory mediators, such as IFN-, TNF-, lipopolysaccharide (LPS), and viral proteins, can activate indoleamine 2,3 dioxygenase (IDO-1), subsequently activating the KP

Simultaneous Quantification of TB-500 and Its Metabolites in In-Vitro Experiments and Rats by UHPLC-Q-Exactive Orbitrap MS/MS and Their Screening by Wound Healing Activities In-Vitro, Rahaman KA, Muresan AR, Min H, Son J, Han HS, Kang MJ, Kwon OS, Journal of Chromatography B, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2024;1235:124033

57 A high toxicity line also exists parallel to the probable toxicity line, and this begins at 300 g/mL at 4 hours, equating to a 90% incidence of severe hepatotoxicity and 24% mortality